McKesson Corporation logo

McKesson Corporation (MCK)

Market Closed
5 Dec, 20:00
NYSE NYSE
$
808. 62
-5.56
-0.68%
$
110.46B Market Cap
17.39 P/E Ratio
2.84% Div Yield
447,038 Volume
25.95 Eps
$ 814.18
Previous Close
Day Range
806.29 818.92
Year Range
558.13 895.58
Want to track MCK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 59 days
McKesson (MCK) Tops Q1 Earnings Estimates

McKesson (MCK) Tops Q1 Earnings Estimates

McKesson (MCK) came out with quarterly earnings of $7.88 per share, beating the Zacks Consensus Estimate of $7.16 per share. This compares to earnings of $7.27 per share a year ago.

Zacks | 1 year ago
McKesson misses quarterly revenue as U.S. pharmaceutical segment weighs

McKesson misses quarterly revenue as U.S. pharmaceutical segment weighs

McKesson Corp reported weaker-than-expected first-quarter revenue on Wednesday due to soft demand for branded and specialty drugs that dragged sales down in its U.S. pharmaceuticals segment.

Reuters | 1 year ago
3 Healthcare Stocks Positioned for Possible Market Outperformance

3 Healthcare Stocks Positioned for Possible Market Outperformance

So far in 2024, healthcare stocks have run into periodic earnings challenges compared to historical first quarters. For example, quarterly earnings for healthcare stocks across the board were down 25% compared to first-quarter 2023 earnings.

Investorplace | 1 year ago
Here's Why McKesson (MCK) is a Strong Momentum Stock

Here's Why McKesson (MCK) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Should You Buy, Sell or Hold McKesson (MCK) Before Q1 Earnings?

Should You Buy, Sell or Hold McKesson (MCK) Before Q1 Earnings?

McKesson's (MCK) first-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.

Zacks | 1 year ago
Unlocking Q1 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics

Unlocking Q1 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics

Beyond analysts' top -and-bottom-line estimates for McKesson (MCK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.

Zacks | 1 year ago
McKesson (MCK) Advances While Market Declines: Some Information for Investors

McKesson (MCK) Advances While Market Declines: Some Information for Investors

McKesson (MCK) reachead $629.09 at the closing of the latest trading day, reflecting a +1.96% change compared to its last close.

Zacks | 1 year ago
McKesson (MCK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

McKesson (MCK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know

McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know

In the latest trading session, McKesson (MCK) closed at $600.16, marking a +0.74% move from the previous day.

Zacks | 1 year ago
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It

McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It

McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 1 year ago
McKesson (MCK) Increases Despite Market Slip: Here's What You Need to Know

McKesson (MCK) Increases Despite Market Slip: Here's What You Need to Know

McKesson (MCK) closed at $585.74 in the latest trading session, marking a +0.47% move from the prior day.

Zacks | 1 year ago
McKesson (MCK) Gains 26% Year to Date: What's Backing the Rally?

McKesson (MCK) Gains 26% Year to Date: What's Backing the Rally?

McKesson's (MCK) shares have risen 1.5% year to date on the back of solid fundamentals. Increasing volumes of prescription and specialty drugs boost the top line.

Zacks | 1 year ago
Loading...
Load More